APA (7th ed.) Citation

Alberer, M., Gnad-Vogt, U., Hong, H. S., Mehr, K. T., Backert, L., Finak, G., . . . Hong, H. S. (2017). Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: An open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet, 390(10101), 1511. https://doi.org/10.1016/S0140-6736(17)31665-3

Chicago Style (17th ed.) Citation

Alberer, Martin, et al. "Safety and Immunogenicity of a MRNA Rabies Vaccine in Healthy Adults: An Open-label, Non-randomised, Prospective, First-in-human Phase 1 Clinical Trial." Lancet 390, no. 10101 (2017): 1511. https://doi.org/10.1016/S0140-6736(17)31665-3.

MLA (9th ed.) Citation

Alberer, Martin, et al. "Safety and Immunogenicity of a MRNA Rabies Vaccine in Healthy Adults: An Open-label, Non-randomised, Prospective, First-in-human Phase 1 Clinical Trial." Lancet, vol. 390, no. 10101, 2017, p. 1511, https://doi.org/10.1016/S0140-6736(17)31665-3.